Display options
Cite
Hanania NA, Papi A, Anzueto A, et al. Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD. ERJ Open Res. 2020;6(2)doi: 10.1183/23120541.00187-2019.
Hanania, N. A., Papi, A., Anzueto, A., Martinez, F. J., Rossman, K. A., Cappelletti, C. S., Duncan, E. A., Nyberg, J. S., & Dorinsky, P. M. (2020). Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD. ERJ open research, 6(2), . https://doi.org/10.1183/23120541.00187-2019
Hanania, Nicola A, et al. "Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD." ERJ open research vol. 6,2 (2020). doi: https://doi.org/10.1183/23120541.00187-2019
Hanania NA, Papi A, Anzueto A, Martinez FJ, Rossman KA, Cappelletti CS, Duncan EA, Nyberg JS, Dorinsky PM. Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD. ERJ Open Res. 2020 Apr 27;6(2). doi: 10.1183/23120541.00187-2019. eCollection 2020 Apr. PMID: 32363206; PMCID: PMC7184113.
Copy Download .nbib Format: NLM
Share it on

ERJ Open Res. 2020 Apr 27;6(2). doi: 10.1183/23120541.00187-2019. eCollection 2020 Apr.

Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD.

ERJ open research

Nicola A Hanania, Alberto Papi, Antonio Anzueto, Fernando J Martinez, Kimberly A Rossman, Christy S Cappelletti, Elizabeth A Duncan, Jack S Nyberg, Paul M Dorinsky

Affiliations

  1. Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX, USA.
  2. Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, Italy.
  3. Pulmonary Medicine and Critical Care, University of Texas Health Science Center and South Texas Veterans Health Care System, San Antonio, TX, USA.
  4. Joan and Sanford I. Weill Dept of Medicine, Weill Cornell Medicine, New York, NY, USA.
  5. AstraZeneca, Morristown, NJ, USA.
  6. AstraZeneca, Durham, NC, USA.
  7. Former employee of AstraZeneca, Morristown, NJ, USA.

PMID: 32363206 PMCID: PMC7184113 DOI: 10.1183/23120541.00187-2019

Abstract

Inhaled corticosteroid/long-acting β

Copyright ©ERS 2020.

Conflict of interest statement

Conflict of interest: N.A. Hanania has received personal fees for serving on advisory boards or as a consultant for AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Mylan, Novartis, Sanofi Genzyme

References

  1. Lancet Respir Med. 2016 May;4(5):390-8 - PubMed
  2. BMJ. 2013 May 29;346:f3306 - PubMed
  3. Am J Respir Crit Care Med. 2007 Jul 15;176(2):162-6 - PubMed
  4. Eur Respir J. 2003 Dec;22(6):912-9 - PubMed
  5. Eur Respir J. 2003 Jan;21(1):74-81 - PubMed
  6. Respir Med. 2019 Oct - Nov;158:59-66 - PubMed
  7. Eur Respir J. 2017 Jun 22;49(6): - PubMed
  8. Am J Respir Crit Care Med. 1999 Jan;159(1):179-87 - PubMed
  9. Eur Respir J. 2018 Sep 16;52(3): - PubMed
  10. COPD. 2009 Oct;6(5):320-9 - PubMed
  11. Respir Med. 2017 Nov;132:31-41 - PubMed
  12. Int J Chron Obstruct Pulmon Dis. 2017 Oct 19;12:3055-3064 - PubMed
  13. Lancet Respir Med. 2015 Jun;3(6):435-42 - PubMed
  14. Eur Respir J. 2018 Dec 13;52(6): - PubMed
  15. J Allergy Clin Immunol. 2018 Jun;141(6):2037-2047.e10 - PubMed
  16. Respirology. 2013 Jul;18(5):866-73 - PubMed
  17. Thorax. 2013 Nov;68(11):1029-36 - PubMed
  18. N Engl J Med. 2007 Feb 22;356(8):775-89 - PubMed
  19. Drugs. 2008;68(14):1975-2000 - PubMed
  20. Int J Chron Obstruct Pulmon Dis. 2017 Apr 05;12:1071-1084 - PubMed
  21. Drugs. 2009;69(5):549-65 - PubMed
  22. Eur Respir J. 2004 Jun;23(6):932-46 - PubMed
  23. Lancet. 2003 Feb 8;361(9356):449-56 - PubMed
  24. Arch Bronconeumol. 2020 Feb;56(2):65-67 - PubMed
  25. Lancet Respir Med. 2018 Oct;6(10):747-758 - PubMed
  26. Am J Respir Crit Care Med. 2015 Aug 15;192(4):523-5 - PubMed
  27. Lancet Respir Med. 2018 Feb;6(2):117-126 - PubMed
  28. Respir Med. 2012 Feb;106(2):257-68 - PubMed
  29. AAPS PharmSciTech. 2018 Feb;19(2):837-844 - PubMed
  30. Langmuir. 2012 Oct 23;28(42):15015-23 - PubMed

Publication Types